Cell therapy Omisirge receives FDA approval for blood cancer patients

The US Food and Drug Administration (FDA) has approved Gamida Cell’s allogeneic cell therapy, Omisirge (omidubicel-onlv), for blood cancer patients.

Related Keywords

United States ,Kiryat Gat ,Hadarom ,Israel ,American ,Peter Marks ,Stevenm Devine ,Abbey Jenkins ,National Marrow Donor Program Be ,American Society Of Hematology ,Biologics Evaluation ,Gamida Cell ,American Society ,Chief Medical Officer ,National Marrow Donor ,African American ,Adding Omisirge ,Omisirge Phase ,Cell Assist ,Markets Amp Regulations ,Cell Amp Gene Therapies ,Blood Cancers ,Stem Cell ,Cell Therapy ,